Patent Assignment
Reel/Frame 044637/0898
Change of Name
Recorded: 2017-10-31
Pages: 4
Assignor
ANGIOBLAST SYSTEMS, INC.
Executed: 2011-10-04
Assignee
MESOBLAST, INC.
275 MADISON AVE, 4TH FLOOR, NEW YORK, NEW YORK, 10016
Covered Property
(1)
Treatment of Excessive Neovascularization
Application:
15/788,438 →
Publication:
US 2018/0369286
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 27, 2017
From: RAKOCZY, PIROSKA ELIZABETH
To: VISOGENE PTY LTD
Reel/Frame 043970/0856 →
Assignment of Assignor's Interest
Oct 30, 2017
From: VISOGENE PTY LTD
To: ANGIOBLAST SYSTEMS, INC.
Reel/Frame 043984/0157 →
Intellectual Property Security Agreement
Mar 28, 2018
From: MESOBLAST INTERNATIONAL SARL
To: HERCULES CAPITAL, INC., AS ADMINISTRATIVE AND COLLATERAL AGENT
Reel/Frame 045759/0917 →
Security Interest
Dec 10, 2021
From: MESOBLAST LIMITED ACN 109 431 870; MESOBLAST UK LIMITED; MESOBLAST, INC. (FORMERLY KNOWN AS ANGIOBLAST, INC.); MESOBLAST INTERNATIONAL SÀRL
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 058957/0447 →
Release of Intellectual Property Security Agreement at Reel/Frame No. 45759/0917
Jul 30, 2025
From: HERCULES CAPITAL, INC., AS AGENT
To: MESOBLAST INTERNATIONAL SARL
Reel/Frame 072297/0753 →
Release of Security Interest in Intellectual Property
Jan 2, 2026
From: OAKTREE FUND ADMINISTRATION, LLC, AS AGENT
To: MESOBLAST LIMITED; MESOBLAST UK LIMITED; MESOBLAST, INC. (FORMERLY KNOWN AS ANGIOBLAST, INC.); MESOBLAST INTERNATIONAL SÀRL
Reel/Frame 074174/0183 →